https://www.cnbc.com/2022/08/08/goldman-sachs-says-buy-this-biopharma-stock-thats-poised-to-rally-nearly-40percent-from-here.html
0
0
Goldman Sachs says buy this biopharma stock that's poised to rally nearly 40% from here - CNBC
+ 10 more
8/8/22 at 5:07am
Organization
CNBC
Author
Samantha Subin
Details
32 words
Summarize
Business & Industrial Business News Business Finance Goldman Sachs biopharma stock CNBC Rhythm Pharmaceuticals
Goldman Sachs says it's time for investors to put their money in Rhythm Pharmaceuticals
Create an account or login to join the discussion